A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

Completed · Phase 2

Conditions studied: Schizophrenia, Bipolar Disorder, Schizoaffective Disorder

In brief

The purpose of this study is to evaluate the safety and tolerability of oral ziprasidone in children and teens with psychotic disorders

Key facts

Study ID

NCT00650611

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

63

Starts

2003-12-01

Expected to finish

2005-03-01

Last updated by the study team

2021-02-21

Who can join

Age: 10 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children and teens with Bipolar I Disorder (manic or mixed), schizophrenia or schizoaffective disorder
• Willingness to discontinue all antipsychotic medications during the study period

You may not qualify if…

• Patients who are clinically stable on treatments that are well tolerated
• Substance-induced psychotic disorders

Where it is running

• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Altamonte Springs, Florida, United States
• Pfizer Investigational Site — Libertyville, Illinois, United States
• Pfizer Investigational Site — Lexington, Kentucky, United States
• Pfizer Investigational Site — Belmont, Massachusetts, United States
• Pfizer Investigational Site — Brighton, Massachusetts, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Turnersville, New Jersey, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
• Pfizer Investigational Site — Kirkland, Washington, United States
• Pfizer Investigational Site — Kirkland, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.